Article info
Lung cancer
Original article
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
- Correspondence to Professor D Neil Watkins, Monash Institute of Medical Research, Monash University, 27-31 Wright St, Clayton, VIC 3168, Australia; neil.watkins{at}monash.edu and Dr Gavin Wright, Department of Surgical Oncology, St Vincent's Hospital, 55 Victoria Parade, Fitzroy, VIC 3065, Australia; gavin.wright{at}svhm.org.au
Citation
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
Publication history
- Received November 19, 2012
- Revised June 3, 2013
- Accepted June 24, 2013
- First published July 22, 2013.
Online issue publication
November 07, 2013
Article Versions
- Previous version (22 July 2013).
- Previous version (7 August 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/